UPDATE: And now it’s official. Pelfrey will undergo Tommy John surgery tomorrow.
While not quite official yet, the Mets just announced that Mike Pelfrey will travel to Alabama tomorrow to see Dr. James Andrews and is expected to undergo Tommy John elbow surgery.
Pelfrey pitched well through three starts, including eight innings of one-run ball his last time out, but was diagnosed with a partially torn ulnar collateral ligament earlier this week.
Surgery would knock him out for the entire season and perhaps part of 2013 as well, likely ending his Mets career after seven years and 149 starts. He’ll be under team control via arbitration next season, but because Pelfrey is making $5.8 million this year and can only take a 20 percent pay cut he’ll almost surely be non-tendered.
MLB.com’s Brian McTaggart reports that Astros first baseman Jonathan Singleton has been suspended 100 games after testing positive for a drug of abuse for a third time. Minor league pitcher Dean Deetz has been suspended 80 games after testing positive for Dehydroclormethyltestosterone.
Singleton, 26, has had issues with marijuana in the past and opened up about his addiction several years ago. He said, “At this point it’s pretty evident to me that I’m a drug addict. I don’t openly tell everyone that, but it’s pretty apparent to myself.” He added, “I know that I enjoy smoking weed, I enjoy being high and I can’t block that out of my mind that I enjoy that. So I have to work against that.”
Singleton hasn’t played in the majors since 2015. Last season, after going all the way back to Double-A Corpus Christi, he hit .205/.376/.397 with 18 home runs and 62 RBI in 500 plate appearances.
Deetz, 24, was selected by the Astros in the 11th round of the 2014 draft. Between Corpus Christi and Triple-A Fresno last season, the right-hander posted a 4.25 ERA with a 97/50 K/BB ratio in 84 2/3 innings of work. He denies knowingly using a PED, per ESPN’s Keith Law.